SO
Highly rated in
6
conditions
Highly rated in
6
conditions

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

About Dr. Seung-june J. Oh

Seung-june Oh is in Busan, Republic of Korea. Dr. Oh is highly rated in 6 conditions, according to our data. Their top areas of expertise are Enlarged Prostate, Bladder Outlet Obstruction, Urinary Incontinence, and Neurogenic Bladder.

Their clinical research consists of co-authoring 152 peer reviewed articles and participating in 212 clinical trials in the past 15 years.

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Locations
  Busan, KR
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
Korea Maritime And Ocean University
 
Busan, KR 
 0.1 km
In-seok Park is in Busan, Republic of Korea. They have been an author on 41 peer reviewed articles in the past 15 years.
Highly rated in
0
conditions
Himnaera Hospital
 
Busan, KR 
 0.1 km
Ju-eun Kim is in Busan, Republic of Korea. They have been an author on 20 peer reviewed articles in the past 15 years.
Highly rated in
0
conditions
Dong A University College Of Medicine
 
Busan, KR 
 0.1 km
Sung Oh is in Busan, Republic of Korea. They have been an author on 216 peer reviewed articles and participated in 78 clinical trials in the past 15 years.